Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Isotope Labeling . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced stable isotope labeling synthesis of pyraoxystrobin via CN107674027B. High purity >98%, scalable route for residue analysis standards.
Patent CN112881542A details a high-purity synthesis of Danofloxacin-D3. Discover cost-effective isotope labeling solutions for veterinary pharmaceutical analysis and supply chain optimization.
Novel patent CN113817003B details stable tritium labeling for catalpol. Enables cost reduction in pharmaceutical intermediate manufacturing and ensures supply chain reliability for ADME studies.
Advanced 5-step synthesis for >98% purity deuterated betamethasone. Optimized route for pharmacokinetic studies and API manufacturing efficiency ensuring supply continuity.
Novel base-catalyzed method for C4/C5 selective deuteration of triazoles. High purity, mild conditions, scalable for drug metabolism studies.
Patent CN113024565B details a stable C-14 ibrutinib synthesis. Enhance environmental safety research with high-purity radiochemical intermediates and scalable production.
Advanced synthesis of stable isotope labeled tauryl amine hydrochloride via CN114539106A. Delivers >98% isotopic abundance and >99% purity for pharmacokinetic research.
Novel stable isotope labeling method ensures high purity and supply reliability for residue detection standards and agrochemical intermediate manufacturing.
Patent CN111689899B details a novel 4-step synthesis for 13C6-labeled fipronil. High purity >98% ensures reliable agrochemical intermediate supply and cost-effective residue analysis.
Advanced synthesis of double-labeled Furmonertinib for ADME studies. Enhances tracer sensitivity and supply chain reliability for pharmaceutical R&D teams.
Novel synthetic route for cold labeling Thiamphenicol ensures high purity and yield. Offers significant cost reduction and supply chain reliability for veterinary drug detection standards.
Patent CN110028457B reveals a high-yield, three-step synthesis for isotope-labeled sulfadimidine, offering superior purity for veterinary drug analysis and supply chain stability.
Novel patent CN116554013A enables high-purity 13C acetone production with simplified workflow and substantial supply chain cost reduction advantages.
Novel synthesis of Erlotinib-13C6 using Benzene-13C6. Optimized route for metabolic studies. Cost-effective manufacturing solution for global pharma.
Advanced synthesis of stable isotope labeled tritoquinol hydrochloride via CN112358446B. High-purity API intermediate for doping control and metabolic research with optimized supply chain.
Novel patent CN101153013B offers high-yield DL-tyrosine-15N synthesis process. Ensures supply chain reliability and significant cost reduction for global research teams.
Novel patent CN113880704B offers high-purity 18O-labeled aldehydes. Reduces heavy oxygen water loss and simplifies scale-up for pharmaceutical intermediates manufacturing globally.
Novel two-step route for 18O-labeled aldehydes ensures high purity and reduced isotope loss for scalable pharmaceutical intermediate manufacturing and research applications.
Patent CN113061094A details a cost-effective H-D exchange route for Ractopamine-D6. Achieve >98% purity and >96% isotopic abundance for LC-MS food safety testing.
Patent CN114380750B reveals high-yield deuteration route. Enhances supply chain reliability and reduces manufacturing costs for veterinary and pharmaceutical intermediates.